714 assets in Colorectal Cancer

Therapeutic assets addressing Colorectal Cancer, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Zoldonrasib Colorectal Cancer	Revolution Medicines, Inc.	P1/2	CC (43)
e-602 Colorectal Cancer	Palleon Pharmaceuticals, Inc.	P1/2	CC (42)
Nogapendekin Alfa Inbakicept Colorectal Cancer	National Cancer Institute (NCI)	P2	CC (42)
Sotigalimab Colorectal Cancer	M.D. Anderson Cancer Center	P1	CC (42)
Spartalizumab Colorectal Cancer	SOLTI Breast Cancer Research Group	P2	CC (42)
Alnodesertib Colorectal Cancer	Artios Pharma Ltd	P1/2	CC (41)
Alta3263 Colorectal Cancer	Alterome Therapeutics, Inc.	P1	CC (41)
alx2004 Colorectal Cancer	ALX Oncology Inc.	P1	CC (41)
Avotaciclib Colorectal Cancer	BeyondBio Inc.	P1/2	CC (41)
Bbo-11818 Colorectal Cancer	TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)	P1	CC (41)
Bgb-53038 Colorectal Cancer	BeOne Medicines	P1	CC (41)
bnt314 Colorectal Cancer	BioNTech SE	P1/2	CC (41)
bnt327 Colorectal Cancer	BioNTech SE	P1/2	CC (41)
Dupilumab Colorectal Cancer	Dan Feng	P1/2	CC (41)
Epcam Car-T Colorectal Cancer	Zhejiang University	P1	CC (41)
es104 Colorectal Cancer	Elpiscience (Suzhou) Biopharma, Ltd.	P1/2	CC (41)
Glumetinib Colorectal Cancer	Liu Huang	P1/2	CC (41)
Gotistobart Colorectal Cancer	OncoC4, Inc.	P1/2	CC (41)
Immunoglobulin G1 [143-Aspartic Acid,236-Glutamic Acid], Anti-(Human Cytotoxic T-Lymphocyte-Associated Protein 4) (Human Monoclonal Hbm4003 Heavy Chain V-D-J Region) Fusion Protein With Immunoglobulin G1 (Human ?1-Chain C Region), Dimer Colorectal Cancer	Harbour BioMed (Guangzhou) Co. Ltd.	P1	CC (41)
Ineo-Vac-T01 Colorectal Cancer	Ying Yuan, MD	P1	CC (41)
kqb198 Colorectal Cancer	Kumquat Biosciences Inc.	P1	CC (41)
kqb365 Colorectal Cancer	Kumquat Biosciences Inc.	P1	CC (41)
Proagio Colorectal Cancer	University of Alabama at Birmingham	P1	CC (41)
sar445877 Colorectal Cancer	M.D. Anderson Cancer Center	P1	CC (41)
SERINE Colorectal Cancer	The First Affiliated Hospital of Xinxiang Medical College	P1	CC (41)
Spx-303 Colorectal Cancer	SparX Biotech(Jiangsu) Co., Ltd.	P1	CC (41)
Sumarotene Colorectal Cancer	CuraCell TX AB	P1/2	CC (41)
SX682 Colorectal Cancer	National Cancer Institute (NCI)	P1/2	CC (41)
Tgi-5 Colorectal Cancer	Hefei TG ImmunoPharma Co., Ltd.	P1	CC (41)
Triadeno Vaccine Colorectal Cancer	National Cancer Institute (NCI)	P1/2	CC (41)
Uromitexan Colorectal Cancer	CuraCell TX AB	P1/2	CC (41)
Vilamakitug Colorectal Cancer	Centre Georges Francois Leclerc	P1/2	CC (41)
[111in]-fpi-1967 Colorectal Cancer	Fusion Pharmaceuticals Inc.	P1/2	CC (40)
177lu-betabart Colorectal Cancer	Radiopharm Theranostics, Ltd	P1/2	CC (40)
[18F]FPyQCP Colorectal Cancer	Blue Earth Diagnostics	P1/2	CC (40)
[203pb]pb-psv359 Colorectal Cancer	Perspective Therapeutics	P1/2	CC (40)
[212pb]pb-psv359 Colorectal Cancer	Perspective Therapeutics	P1/2	CC (40)
[225Ac]-FPI-1966 Colorectal Cancer	Fusion Pharmaceuticals Inc.	P1/2	CC (40)
64cu-lnth-1363s Colorectal Cancer	Lantheus Medical Imaging	P1/2	CC (40)
a2b395 Colorectal Cancer	A2 Biotherapeutics Inc.	P1/2	CC (40)
a2b530 Colorectal Cancer	A2 Biotherapeutics Inc.	P1/2	CC (40)
a2b543 Colorectal Cancer	A2 Biotherapeutics Inc.	P1/2	CC (40)
a2b694 Colorectal Cancer	A2 Biotherapeutics Inc.	P1/2	CC (40)
Acetylcysteine Colorectal Cancer	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	P1/2	CC (40)
Afnt-211 Colorectal Cancer	Affini-T Therapeutics, Inc.	P1/2	CC (40)
ak119 Colorectal Cancer	Akeso	P1/2	CC (40)
Ale.P03 Colorectal Cancer	Alentis Therapeutics AG	P1/2	CC (40)
Alintegimod Colorectal Cancer	7 Hills Pharma, LLC	P1/2	CC (40)
Amxt1501 Colorectal Cancer	Aminex Therapeutics, Inc.	P1/2	CC (40)
Apl-5125 Colorectal Cancer	Apollo Therapeutics Ltd	P1/2	CC (40)

Showing 401 to 450 of 714 assets

PreviousPage 9 of 15Next